Literature DB >> 19238500

Developmentally regulated Ca2+-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility.

Tetsushi Sadakata1, Teiichi Furuichi.   

Abstract

The postnatal development of the cerebellum is accomplished via a series of cytogenetic and morphogenetic events encoded in the genome. To decipher the underlying genetic basis of these events we have systematized the spatio-temporal gene expression profiles during mouse cerebellar development in the Cerebellar Development Transcriptome Database (CDT-DB). Using the CDT-DB, Ca(2+)-dependent activator protein for secretion 2 (CAPS2 or CADPS2) was identified as a developmentally regulated gene that is predominantly expressed in cerebellar granule cells (GCs) with an expression peak around the first or second postnatal week. CAPS2 protein is concentrated in parallel fiber (PF) terminals and is associated with secretory vesicles containing brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3). CAPS2 enhances release of BDNF and NT-3, both of which are essential for normal cerebellar development. CAPS2-deficient (CAPS2(-/-)) mice show reduced secretion of BDNF and NT-3; consequently, the cerebella of these mice exhibit developmental deficits, such as delayed development and increased cell death in GCs, fewer branched dendrites on Purkinje cells (PCs), and loss of the intercrural fissure. The PF-PC synapses have aberrant cytoarchitectures and electrophysiological properties. These abnormal cellular and morphological phenotypes are more severe around the cerebellar vermis, in which hypoplasia has been reported in autism patients. Moreover, CAPS2(-/-) mice had fewer cortical and hippocampal parvalbumin-positive interneurons and some autistic-like behavioral phenotypes. In the CAPS2 genes of some autistic patients an aberrant splicing variant and non-synonymous SNPs have been identified. These recent studies implicate CAPS2 in autism susceptibility. Therefore, CAPS2(-/-) mice will be a useful model animal in which to study aspects of the neuropathology and behaviors characteristic of developmental disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19238500     DOI: 10.1007/s12311-009-0097-5

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  79 in total

1.  Membrane association domains in Ca2+-dependent activator protein for secretion mediate plasma membrane and dense-core vesicle binding required for Ca2+-dependent exocytosis.

Authors:  Ruslan N Grishanin; Vadim A Klenchin; Kelly M Loyet; Judith A Kowalchyk; Kyoungsook Ann; Thomas F J Martin
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

2.  Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain.

Authors:  K P Das; S L Chao; L D White; W T Haines; G J Harry; H A Tilson; S Barone
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

3.  Ca2+-dependent activator protein for secretion 1 is critical for constitutive and regulated exocytosis but not for loading of transmitters into dense core vesicles.

Authors:  Yoshihito Fujita; Ainan Xu; Li Xie; Lakshmanan Arunachalam; Ting-Chieh Chou; Tiandan Jiang; Soon-Kwang Chiew; John Kourtesis; Li Wang; Herbert Y Gaisano; Shuzo Sugita
Journal:  J Biol Chem       Date:  2007-05-31       Impact factor: 5.157

4.  The docking protein Cas links tyrosine phosphorylation signaling to elongation of cerebellar granule cell axons.

Authors:  Jinhong Huang; Ryuichi Sakai; Teiichi Furuichi
Journal:  Mol Biol Cell       Date:  2006-05-10       Impact factor: 4.138

5.  Neurotrophin-3 controls proliferation of granular precursors as well as survival of mature granule neurons in the developing rat cerebellum.

Authors:  R Katoh-Semba; I K Takeuchi; R Semba; K Kato
Journal:  J Neurochem       Date:  2000-05       Impact factor: 5.372

6.  Characterization of the responses of Purkinje cells to neurotrophin treatment.

Authors:  L Lärkfors; R M Lindsay; R F Alderson
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

7.  Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.

Authors:  Graeme Eisenhofer; Thanh-Truc Huynh; Abdel Elkahloun; John C Morris; Gennady Bratslavsky; W Marston Linehan; Zhengping Zhuang; Brian M Balgley; Cheng S Lee; Massimo Mannelli; Jacques W M Lenders; Stefan R Bornstein; Karel Pacak
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

8.  CAPS acts at a prefusion step in dense-core vesicle exocytosis as a PIP2 binding protein.

Authors:  Ruslan N Grishanin; Judith A Kowalchyk; Vadim A Klenchin; Kyougsook Ann; Cynthia A Earles; Edwin R Chapman; Roy R L Gerona; Thomas F J Martin
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

9.  Identification of secretory granule phosphatidylinositol 4,5-bisphosphate-interacting proteins using an affinity pulldown strategy.

Authors:  Shona L Osborne; Tristan P Wallis; Jose L Jimenez; Jeffrey J Gorman; Frederic A Meunier
Journal:  Mol Cell Proteomics       Date:  2007-04-20       Impact factor: 5.911

10.  Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents.

Authors:  P Ernfors; K F Lee; J Kucera; R Jaenisch
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

View more
  27 in total

1.  Dense core vesicle release: controlling the where as well as the when.

Authors:  Stephen Nurrish
Journal:  Genetics       Date:  2014-03       Impact factor: 4.562

Review 2.  Systematizing and cloning of genes involved in the cerebellar cortex circuit development.

Authors:  Teiichi Furuichi; Yoko Shiraishi-Yamaguchi; Akira Sato; Tetsushi Sadakata; Jinhong Huang; Yo Shinoda; Kanehiro Hayashi; Yuriko Mishima; Mineko Tomomura; Hirozumi Nishibe; Fumio Yoshikawa
Journal:  Neurochem Res       Date:  2011-01-18       Impact factor: 3.996

Review 3.  Brain-derived neurotrophic factor in the airways.

Authors:  Y S Prakash; Richard J Martin
Journal:  Pharmacol Ther       Date:  2014-02-19       Impact factor: 12.310

4.  Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms.

Authors:  Destanie R Rose; Houa Yang; Gloria Serena; Craig Sturgeon; Bing Ma; Milo Careaga; Heather K Hughes; Kathy Angkustsiri; Melissa Rose; Irva Hertz-Picciotto; Judy Van de Water; Robin L Hansen; Jacques Ravel; Alessio Fasano; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2018-03-20       Impact factor: 7.217

5.  Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice.

Authors:  Kazuhiro Mitsumura; Nobutake Hosoi; Nobuhiko Furuya; Hirokazu Hirai
Journal:  J Physiol       Date:  2011-05-09       Impact factor: 5.182

Review 6.  Dual-transmitter neurons: functional implications of co-release and co-transmission.

Authors:  Christopher E Vaaga; Maria Borisovska; Gary L Westbrook
Journal:  Curr Opin Neurobiol       Date:  2014-05-13       Impact factor: 6.627

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  Functional annotation of genes overlapping copy number variants in autistic patients: focus on axon pathfinding.

Authors:  Silvia Sbacchi; Francesco Acquadro; Ignazio Calò; Francesco Calì; Valentino Romano
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

9.  Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice.

Authors:  Tetsushi Sadakata; Yo Shinoda; Megumi Oka; Yukiko Sekine; Yumi Sato; Chihiro Saruta; Hideki Miwa; Mika Tanaka; Shigeyoshi Itohara; Teiichi Furuichi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-03       Impact factor: 11.205

10.  TRPC3 regulates release of brain-derived neurotrophic factor from human airway smooth muscle.

Authors:  Pawan K Vohra; Michael A Thompson; Venkatachalem Sathish; Alexander Kiel; Calvin Jerde; Christina M Pabelick; Brij B Singh; Y S Prakash
Journal:  Biochim Biophys Acta       Date:  2013-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.